Follow the company. Check the evidence.
Public records connected to stocks traded by Congress. See what changed, when it became public, and the original source.
LLY: second_quarter 2026 lobbying report
Medicare & Medicaid payment and coverage issues, lobbying related to pharmaceutical policy federal budget issues Lobbying related to pharmaceutical policy
Public: Jul 20, 2026, 1:53 PM EDTOriginal source ↗2 congressional households disclosed purchases in the past 90 days. See the trades
LLY: second_quarter 2026 lobbying report
Issues related to intellectual property protection, enforcement and market access issues within trade negotiations; supply chain management; issues related to China trade; Issues related to global health; and issues related to tariffs. Issues related to intellectual property protection, enforcement and market access issues within trade negotiations; supply chain management; issues related to China trade; Issues related to global health; and issues related to tariffs.
Public: Jul 20, 2026, 9:22 AM EDTOriginal source ↗2 congressional households disclosed purchases in the past 90 days. See the trades
LLY: second_quarter 2026 lobbying report
Issues related to biotechnology legislation Diagnostic tests Clinical trial issues Issues related to supply chain Issues related to the pharmaceutical industry Treat and Reduce Obesity Act Pharmaceutical tariffs Safe Drugs Act
Public: Jul 20, 2026, 8:58 AM EDTOriginal source ↗2 congressional households disclosed purchases in the past 90 days. See the trades
LLY: second_quarter 2026 lobbying report
A lobbying activity report was filed. Income and expenses are separate reporting measures and must not be added together.
Public: Jul 19, 2026, 4:55 PM EDTOriginal source ↗2 congressional households disclosed purchases in the past 90 days. See the trades
LLY: second_quarter 2026 lobbying report
General Healthcare issues, including drug accessibility, importation and innovation policies.
Public: Jul 17, 2026, 3:41 PM EDTOriginal source ↗2 congressional households disclosed purchases in the past 90 days. See the trades
LLY: second_quarter 2026 lobbying report
Issues related to healthcare Issues related to trade
Public: Jul 16, 2026, 2:07 PM EDTOriginal source ↗2 congressional households disclosed purchases in the past 90 days. See the trades
LLY: second_quarter 2026 lobbying report
Pharmaceutical intellectual property issues Intellectual property; 340B Program; Medicare & Medicaid prescription drug diagnosis and screening reimbursement pricing, coverage, value and access; Implementation of the "Inflation Reduction Act" (HR.5376); CMS National Coverage Determination on Alzheimer's disease Multi-lateral threats to IP and the biopharmaceutical industry; Drug importation; Prescription drug value, access and quality Issues related to intellectual property protection and market access within current trade negotiations. Canada IP; USMCA implementation; Mexico patent linkage; Sp
Public: Jul 16, 2026, 12:26 PM EDTOriginal source ↗2 congressional households disclosed purchases in the past 90 days. See the trades
LLY: second_quarter 2026 lobbying report
There is no specific bill filed. Engagement relates to issues on healthcare and trade. There is no specific bill filed. Engagement relates to issues on healthcare and trade.
Public: Jul 15, 2026, 3:04 PM EDTOriginal source ↗2 congressional households disclosed purchases in the past 90 days. See the trades
LLY: second_quarter 2026 lobbying report
Alzheimer's Disease. Anti Obesity Medication. Medicare/Medicaid Coverage and Reimbursement. PDUFA. 340B Program. Issues related to drug compounding.
Public: Jul 12, 2026, 8:52 PM EDTOriginal source ↗2 congressional households disclosed purchases in the past 90 days. See the trades
LLY: second_quarter 2026 lobbying report
Monitored Issues and advised clients on matters related to Pharmaceutical supply chain security and resiliency.
Public: Jul 10, 2026, 11:42 AM EDTOriginal source ↗2 congressional households disclosed purchases in the past 90 days. See the trades
LLY: second_quarter 2026 lobbying report
Issues related to prescription drug value, including implementation of the Inflation Reduction Act (PL 117-169), and implementation of Executive Order 14273, Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients. Issues related to FDA regulation of pharmaceuticals. Issues related to the 340B program. Issues related to treatments for Alzheimers therapeutics.
Public: Jul 9, 2026, 10:22 AM EDTOriginal source ↗2 congressional households disclosed purchases in the past 90 days. See the trades
LLY: fourth_quarter 2019 lobbying report
General Healthcare Issues pertaining to Eli Lilly and Company, including but not limited to drug pricing, importation and innovation policies.
Public: Jul 6, 2026, 12:12 PM EDTOriginal source ↗2 congressional households disclosed purchases in the past 90 days. See the trades
Endo Operations Limited, et al.; Withdrawal of Approval of 34 New Drug Applications
The Food and Drug Administration (FDA or Agency) is withdrawing approval of 34 new drug applications (NDAs) from multiple applicants. The applicants notified the Agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.
Public: Jul 6, 2026Original source ↗2 congressional households disclosed purchases in the past 90 days. See the trades
LLY: Other company developments
Filed 8-K for an event or period dated 2026-05-20. Other company developments.
2 congressional households disclosed purchases in the past 90 days. See the trades
Connections describe public records, not evidence of wrongdoing or a prediction of returns. Event dates can precede publication by days or months. When a source has no public-release timestamp, we show when we first observed it.
Source coverage
Coverage is growing across companies already tracked here. A scan can return no matching records. This feed is not a complete record of every filing or agency action.
- SEC EDGAR
- Current across tracked companies505 of 505 companies scanned in the past 12 hoursLatest successful company scan: Nov 12, 2026, 2:26 PM EST
- USAspending
- Collection in progress72 of 548 companies scanned in the past 12 hoursLatest successful company scan: Nov 12, 2026, 2:27 PM EST
- SAM.gov
- Awaiting company connections
- Lobbying disclosures
- Not yet scanned0 of 548 companies scanned in the past 12 hours
- Congress.gov
- Current across tracked companies5 of 5 companies scanned in the past 12 hoursLatest successful company scan: Nov 12, 2026, 2:19 PM EST
- Federal Register
- Collection in progress296 of 548 companies scanned in the past 12 hoursLatest successful company scan: Nov 12, 2026, 2:27 PM EST
- Regulations.gov
- Partial coverage — some requests unavailable32 of 53 companies scanned in the past 12 hoursLatest successful company scan: Nov 12, 2026, 2:19 PM EST
- FEC campaign finance
- Stale — refresh overdue0 of 548 companies scanned in the past 12 hoursLatest successful company scan: Nov 11, 2026, 1:28 PM EST